Suppr超能文献

特定神经调节剂对人类难治性慢性咳嗽的疗效:一项系统评价和荟萃分析。

The efficacy of specific neuromodulators on human refractory chronic cough: a systematic review and meta-analysis.

作者信息

Wei Weili, Liu Ruilin, ZhangTong Yangzi, Qiu Zhongmin

机构信息

Department of Respiratory Medicine, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.

出版信息

J Thorac Dis. 2016 Oct;8(10):2942-2951. doi: 10.21037/jtd.2016.10.51.

Abstract

BACKGROUND

There have been several published reports on the use of orally administered, specific centrally acting medicines for the treatment of idiopathic cough; however, there is no extant systematic review of randomized controlled trials (RCTs) that evaluated their efficacy and safety for the treatment of idiopathic cough in human beings.

METHODS

We conducted a series of definitive systematic reviews and meta-analyses of RCTs. Claims data from the MEDLINE, EMBASE, LILACS, CBM, CNKI, VIP, Wan Fang, and Cochrane Library databases were used. We also reviewed articles and reference lists of relevant articles pertaining to human subjects published prior to March 26, 2016. No language restrictions were imposed. Two authors independently reviewed the titles and abstracts of the retrieved studies, which were matched using Review Manager 5.3 software. Disagreements were resolved by consensus. The outcome data were the number of subjects whose symptoms declined, measured by cough or Leicester Cough Questionnaire (LCQ) score. Random effect meta-analyses were used to pool the findings. Publication bias was assessed using funnel plots.

RESULTS

Three RCTs, regarding the medicines baclofen, amitriptyline, and gabapentin, were conducted involving 92 persons in total. Our reviews confirmed that baclofen, amitriptyline, and gabapentin show promise in the treatment of cough for select cases of refractory chronic cough. After-treatment relief of cough symptoms was significant (risk ratio =2.41; 95% CI: 1.15-5.04, n=84). Each of the medicines was well tolerated with minimal side effects. Methodological biases in the design and execution of cluster randomized trials might contribute to any selection bias in this review.

CONCLUSIONS

Baclofen, amitriptyline, and gabapentin may be effective 'non-specific' antitussives in clinical settings, although none of them are used in medical assessments or routinely included in the anatomic diagnostic protocol.

摘要

背景

已有多篇关于口服特定中枢性药物治疗特发性咳嗽的报道;然而,尚无对评估其治疗人类特发性咳嗽疗效和安全性的随机对照试验(RCT)进行的系统评价。

方法

我们对RCT进行了一系列确定性系统评价和荟萃分析。使用了MEDLINE、EMBASE、LILACS、CBM、CNKI、VIP、万方和Cochrane图书馆数据库中的索赔数据。我们还查阅了2016年3月26日前发表的有关人类受试者的文章及相关文章的参考文献列表。未设语言限制。两名作者独立查阅检索到的研究的标题和摘要,使用Review Manager 5.3软件进行匹配。分歧通过协商解决。结局数据为症状减轻的受试者数量,通过咳嗽或莱斯特咳嗽问卷(LCQ)评分衡量。采用随机效应荟萃分析汇总研究结果。使用漏斗图评估发表偏倚。

结果

开展了三项关于巴氯芬、阿米替林和加巴喷丁的RCT,共涉及92人。我们的评价证实,巴氯芬、阿米替林和加巴喷丁在治疗某些难治性慢性咳嗽病例的咳嗽方面显示出前景。治疗后咳嗽症状缓解显著(风险比=2.41;95%CI:1.15 - 5.04,n = 84)。每种药物耐受性良好,副作用极小。整群随机试验设计和实施中的方法学偏倚可能导致本评价中的任何选择偏倚。

结论

巴氯芬、阿米替林和加巴喷丁在临床环境中可能是有效的“非特异性”镇咳药,尽管它们均未用于医学评估或常规纳入解剖学诊断方案。

相似文献

2
Gabapentin for chronic refractory cough: A system review and meta-analysis.
Heliyon. 2023 Apr 18;9(5):e15579. doi: 10.1016/j.heliyon.2023.e15579. eCollection 2023 May.
3
Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review.
Otolaryngol Head Neck Surg. 2013 Mar;148(3):374-82. doi: 10.1177/0194599812471817. Epub 2013 Jan 8.
4
Over-the-counter medications for acute cough in children and adults in ambulatory settings.
Cochrane Database Syst Rev. 2004 Oct 18(4):CD001831. doi: 10.1002/14651858.CD001831.pub2.
5
A systematic review and meta-analysis of neuromodulators to treat chronic airway hypersensitivity.
Am J Otolaryngol. 2023 May-Jun;44(3):103815. doi: 10.1016/j.amjoto.2023.103815. Epub 2023 Feb 25.
6
7
Over-the-counter medications for acute cough in children and adults in ambulatory settings.
Cochrane Database Syst Rev. 2001(3):CD001831. doi: 10.1002/14651858.CD001831.
8
Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012536. doi: 10.1002/14651858.CD012536.pub2.
9
Oral traditional Chinese medication for adhesive small bowel obstruction.
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008836. doi: 10.1002/14651858.CD008836.pub2.
10
Second-generation antidepressants for preventing seasonal affective disorder in adults.
Cochrane Database Syst Rev. 2015 Nov 8(11):CD011268. doi: 10.1002/14651858.CD011268.pub2.

引用本文的文献

1
Neuromodulators in Acute and Chronic Cough in Children: An Update from the Literature.
Int J Mol Sci. 2024 Oct 18;25(20):11229. doi: 10.3390/ijms252011229.
3
Efficacy and safety of pharmacotherapy for refractory or unexplained chronic cough: a systematic review and network meta-analysis.
EClinicalMedicine. 2023 Jul 20;62:102100. doi: 10.1016/j.eclinm.2023.102100. eCollection 2023 Aug.
5
Prediction of therapeutic efficacy of gabapentin by Hull Airway Reflux Questionnaire in chronic refractory cough.
Ther Adv Chronic Dis. 2020 Dec 26;11:2040622320982463. doi: 10.1177/2040622320982463. eCollection 2020.
6
Gabapentin versus baclofen for treatment of refractory gastroesophageal reflux-induced chronic cough.
J Thorac Dis. 2020 Sep;12(9):5243-5250. doi: 10.21037/jtd-2020-icc-002.
8
Managing patients with chronic cough: challenges and solutions.
Ther Clin Risk Manag. 2018 Jun 6;14:1041-1051. doi: 10.2147/TCRM.S136036. eCollection 2018.
9
Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions.
Eur Respir Rev. 2018 Feb 7;27(147). doi: 10.1183/16000617.0076-2017. Print 2018 Mar 31.

本文引用的文献

1
Gabapentin for Chronic Refractory Cancer Cough.
Indian J Palliat Care. 2016 Jan-Mar;22(1):94-6. doi: 10.4103/0973-1075.173940.
2
Management of chronic refractory cough.
BMJ. 2015 Dec 14;351:h5590. doi: 10.1136/bmj.h5590.
3
The basolateral amygdala γ-aminobutyric acidergic system in health and disease.
J Neurosci Res. 2016 Jun;94(6):548-67. doi: 10.1002/jnr.23690. Epub 2015 Nov 19.
4
Refractory chronic cough due to gastroesophageal reflux: Definition, mechanism and management.
World J Methodol. 2015 Sep 26;5(3):149-56. doi: 10.5662/wjm.v5.i3.149.
6
NMDA and GABA receptors as potential targets in cough hypersensitivity syndrome.
Curr Opin Pharmacol. 2015 Jun;22:29-36. doi: 10.1016/j.coph.2015.03.002. Epub 2015 Mar 16.
7
Adult and paediatric cough guidelines: Ready for an overhaul?
Pulm Pharmacol Ther. 2015 Dec;35:137-44. doi: 10.1016/j.pupt.2015.01.007. Epub 2015 Feb 11.
8
Arnold's nerve cough reflex: evidence for chronic cough as a sensory vagal neuropathy.
J Thorac Dis. 2014 Oct;6(Suppl 7):S748-52. doi: 10.3978/j.issn.2072-1439.2014.04.22.
9
Modulation of the GABAergic pathway for the treatment of fragile X syndrome.
Neuropsychiatr Dis Treat. 2014 Sep 16;10:1769-79. doi: 10.2147/NDT.S42919. eCollection 2014.
10
Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report.
Chest. 2014 Dec;146(6):1633-1648. doi: 10.1378/chest.14-1481.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验